NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT02973685,HAIC Versus TACE for Large Hepatocellular Carcinoma Staged BCLC A/B.,https://clinicaltrials.gov/study/NCT02973685,,COMPLETED,The purpose of this study is to evaluate the efficacy and safety of hepatic arterial infusion chemotherapy (HAIC) compared with transarterial chemoembolization (TACE) in patients with large hepatocellular carcinoma staged BCLC A/B.,NO,HepatoCellular Carcinoma,PROCEDURE: Hepatic arterial infusion chemotherapy|PROCEDURE: Transarterial chemoembolization|DRUG: Folfox Protocol|DRUG: TACE Drug Protocol,"Overall survival, 24 months","Time to progression, 24 months|Adverse Events, Postoperative adverse events were graded based on CTCAE v4.03, 30 Days after HAIC|Number of of Patients developed Adverse Events, Number of of patients who developed adverse event. Postoperative adverse events were graded based on CTCAE v3.0, 30 Days after HAIC",,Sun Yat-sen University,Guangzhou No.12 People's Hospital|First People's Hospital of Foshan,ALL,"ADULT, OLDER_ADULT",PHASE3,315,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,HCC-S023,2016-10-01,2020-11-28,2020-11-28,2016-11-25,,2023-06-12,"The First People's Hospital of Foshan, Foshan, Guangdong, 510060, China|Cancer Center Sun Yat-sen University, Guangzhou, Guangdong, 510060, China|Guangzhou Twelfth People's Hospital, Guangzhou, Guangdong, 510620, China",
